All News #Library
Biotech
Agios Reports Q4 2025 Financial Results And Business Update
12 Feb 2026 //
GLOBENEWSWIRE
Agios To Host Q4 2025 Financial Results Conference On Feb 12
26 Jan 2026 //
GLOBENEWSWIRE
Agios shares jump as FDA expands approval for Blood Disorder
27 Dec 2025 //
REUTERS
Agios Announces Exclusive Worldwide License Agreement for Novel siRNA
03 Aug 2023 //
GLOBENEWSWIRE
Agios pays $17.5M for Alnylam`s siRNA blood disease program
03 Aug 2023 //
FIERCE BIOTECH

Market Place
Sourcing Support